Archive


Category: Blue Oak Pharma

  • Blue Oak taps AI specialist Exscientia for CNS drug discovery

    US startup Blue Oak Pharma has joined a lengthening list of companies turning to Exscientia of the UK for its expertise in applying artificial intelligence to drug discovery. Waltham, Massachusetts-based Blue Oak –  led by neurobiologist and former Eli Lilly and Sunovion executive Tom Large – will work with Exscientia on new classes of neuropsychiatric […]